GSK Canada today announced the approval of Shingrix (GSK's Recombinant Zoster Vaccine or RZV) in a prefilled syringe. This new presentation removes the need to reconstitute separate vials prior to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results